MD Becker Partners' newsletter covering the life science industry
Cyclacel is a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases. The Company has three orally-available product candidates in clinical development, for which Cyclacel has retained rights in most global markets. Through Cyclacel’s ALIGN Pharmaceuticals subsidiary, the Company markets Xclair® [...]
Agenus Inc. is a biotechnology company working to develop treatments for cancers and infectious diseases. With our strong platform technologies, multiple product candidates are advancing through the clinic. The most suitable patient populations to benefit from our novel vaccine approach have been defined. View the company’s fact sheet (PDF)
Follow MD Becker Partners